ES2078727T3 - Composiciones farmaceuticas. - Google Patents

Composiciones farmaceuticas.

Info

Publication number
ES2078727T3
ES2078727T3 ES92900531T ES92900531T ES2078727T3 ES 2078727 T3 ES2078727 T3 ES 2078727T3 ES 92900531 T ES92900531 T ES 92900531T ES 92900531 T ES92900531 T ES 92900531T ES 2078727 T3 ES2078727 T3 ES 2078727T3
Authority
ES
Spain
Prior art keywords
pharmaceutical compositions
effervescent
compositions
headaches
physiologically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92900531T
Other languages
English (en)
Inventor
Alain Emile Edouard Schaeffer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Glaxo Wellcome SA
Original Assignee
Laboratoires Glaxo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Glaxo SA filed Critical Laboratoires Glaxo SA
Application granted granted Critical
Publication of ES2078727T3 publication Critical patent/ES2078727T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA INVENCION SE REFIERE A COMPOSICIONES FARMACEUTICAS EFERVESCENTES PARA USO ORAL QUE COMPRENDEN UN PAR EFERVESCENTE, QUE SE COMPONE ESENCIALMENTE DE UN COMPONENTE BASE Y DE UN COMPONENTE ACIDO, CUYOS COMPONENTES REACCIONAN EN PRESENCIA DE AGUA PARA GENERAR UN GAS, Y UN COMPUESTO QUE ACTUA COMO UN AGONISTA RECEPTOR SIMILAR AL 5HT1, O UNA SAL ACEPTABLE FISIOLOGICAMENTE O DISOLVENTE DE ELLA COMO INGREDIENTE ACTIVO. TAMBIEN SE DESCRIBEN METODOS PARA LA FABRICACION DE TALES COMPOSICIONES Y PARA SU USO EN EL TRATAMIENTO DE DOLORES DE CABEZA.
ES92900531T 1990-12-21 1991-12-17 Composiciones farmaceuticas. Expired - Lifetime ES2078727T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909027827A GB9027827D0 (en) 1990-12-21 1990-12-21 Pharmaceutical compositions
SG169594A SG169594G (en) 1990-12-21 1994-12-01 Effervescent pharmaceutical compositions containing a 5HT-receptor agonist

Publications (1)

Publication Number Publication Date
ES2078727T3 true ES2078727T3 (es) 1995-12-16

Family

ID=26298162

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92900531T Expired - Lifetime ES2078727T3 (es) 1990-12-21 1991-12-17 Composiciones farmaceuticas.

Country Status (25)

Country Link
EP (1) EP0563094B1 (es)
JP (1) JP3425949B2 (es)
KR (1) KR100188172B1 (es)
AT (1) ATE127688T1 (es)
AU (1) AU654313B2 (es)
BE (1) BE1004182A3 (es)
CA (1) CA2099585C (es)
CH (1) CH684161A5 (es)
CZ (1) CZ281042B6 (es)
DE (1) DE69113062T2 (es)
DK (1) DK0563094T3 (es)
ES (1) ES2078727T3 (es)
FR (1) FR2670674B1 (es)
GB (2) GB9027827D0 (es)
GR (1) GR3017701T3 (es)
HK (1) HK18795A (es)
IE (1) IE914482A1 (es)
IL (1) IL100452A (es)
IT (1) IT1252599B (es)
MX (1) MX9102733A (es)
NZ (1) NZ241098A (es)
RU (1) RU2110992C1 (es)
SG (1) SG169594G (es)
WO (1) WO1992011003A1 (es)
ZA (1) ZA9110052B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2714064B1 (fr) * 1993-12-16 1996-03-08 Edmond Creppy Aspartame pour son application en tant que substance thérapeutiquement active.
RU2189228C1 (ru) * 2001-05-24 2002-09-20 Общество с ограниченной ответственностью "Сантэфарм" Фармацевтическая композиция в форме шипучих растворимых таблеток и способ ее получения
GB0129117D0 (en) * 2001-12-05 2002-01-23 Glaxo Group Ltd Pharmaceutical composition
RU2257891C1 (ru) * 2003-12-31 2005-08-10 ООО "Фармстандарт-Фитофарм-НН" Способ получения композиции в форме шипучих таблеток
US20220257802A1 (en) * 2019-06-07 2022-08-18 Ascelia Pharma AB Compressed solid composition for mri

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
IE59106B1 (en) * 1985-05-31 1994-01-12 Warner Lambert Co A therapeutic effervescent composition and a method of preparing the same
FR2593065B1 (fr) * 1986-01-22 1988-09-09 Smith Kline French Lab Couples effervescents, compositions effervescentes d'antagonistes h2 de l'histamine les contenant et leur preparation.
US4687682A (en) * 1986-05-02 1987-08-18 American Telephone And Telegraph Company, At&T Technologies, Inc. Back sealing of silicon wafers
GB8909793D0 (en) * 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation

Also Published As

Publication number Publication date
HK18795A (en) 1995-02-17
IE914482A1 (en) 1992-07-01
BE1004182A3 (fr) 1992-10-06
IL100452A0 (en) 1992-09-06
ATE127688T1 (de) 1995-09-15
AU654313B2 (en) 1994-11-03
WO1992011003A1 (en) 1992-07-09
EP0563094A1 (en) 1993-10-06
RU2110992C1 (ru) 1998-05-20
ZA9110052B (en) 1992-10-28
GR3017701T3 (en) 1996-01-31
CA2099585A1 (en) 1992-06-22
EP0563094B1 (en) 1995-09-13
CZ122593A3 (en) 1994-02-16
IT1252599B (it) 1995-06-19
ITRM910963A0 (it) 1991-12-20
GB2250917A (en) 1992-06-24
CH684161A5 (fr) 1994-07-29
AU9066591A (en) 1992-07-22
DK0563094T3 (da) 1995-12-04
DE69113062T2 (de) 1996-02-01
KR100188172B1 (ko) 1999-06-01
GB2250917B (en) 1994-10-26
CA2099585C (en) 2003-09-30
ITRM910963A1 (it) 1993-06-20
FR2670674A1 (fr) 1992-06-26
JP3425949B2 (ja) 2003-07-14
GB9027827D0 (en) 1991-02-13
GB9126957D0 (en) 1992-02-19
CZ281042B6 (cs) 1996-06-12
SG169594G (en) 1995-04-28
NZ241098A (en) 1993-07-27
IL100452A (en) 1997-02-18
MX9102733A (es) 1992-09-01
JPH06503826A (ja) 1994-04-28
DE69113062D1 (de) 1995-10-19
FR2670674B1 (fr) 1994-05-13

Similar Documents

Publication Publication Date Title
ES2079210T3 (es) Formulacion farmaceutica de aerosol.
ITFI930247A1 (it) Antagonisti delle tachichinine,procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche.
ES2151083T3 (es) Composiciones orales que contienen ondansetron.
NO20000466D0 (no) Farmasoeytisk preparat for sure, lipofile forbindelser i form av en selvemulgerende formulering
ECSP055609A (es) "Uso de inhibidores de la IkB-quinasa para el tratamiento del dolor"
AR003427A1 (es) Péptidos relacionados con dolastatina, procedimiento para prepararlos, composiciones farmacéuticas que los contienen y el uso de los mismos para la preparación de dichas composiciones farmacéuticas.
ITBO20050388A1 (it) Formulazione mucoadesive utili in dispositivi medici in preparazioni farmaceutiche
AR035927A1 (es) Compuesto de lactama (n)-((s)-2-hidroxi-3-metilbutiril)-1-(l-alaninil)-(s)-1-amino-3-metil-4,5,6,7-tetrahidro-2h-3-benzazepin-2-ona , composicion farmaceutica que lo comprende, procedimiento para la inhibicion de la liberacion de peptido b-amiloide y/o su sintesis que lo emplea y su uso para la fabr
ES2119984T3 (es) Nuevos compuestos propinil bi-aromaticos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
ES2117015T3 (es) Composiciones que contienen sumatriptan.
CO5560558A2 (es) Uso de una composicion de celecoxib para rapido alivio del dolor
ES2072447T3 (es) Locion analgesica externa y procedimiento de preparacion.
AR012671A1 (es) Composiciones farmaceuticas para el tratamiento o profilaxis de la constipacion, los usos de dichas composiciones y los procesos para prepararlos
EA200400689A1 (ru) Фармацевтические и косметические композиции, содержащие ароматические альдегиды, содержащие оксигруппу
ES2063146T3 (es) Composiciones farmaceuticas que contienen acido n-(3,4-dimetoxicinamoil)-antranilico.
CU23241B7 (es) 2-fenil-1-(4(2-aminoetoxi)-benzil)-indol en combinacion con estrogenos
AR011409A1 (es) Derivados de 16-hidroxi-11-(fenil substituido)-estra-4,9-dieno, su utilizacion, un procedimiento para prepararlos, formulaciones farmaceuticasque comprenden a dichos derivados, y un compuesto utilizable como intermediario para prepararlos
DE69711637D1 (de) Aerosolformulierungen
AR044200A1 (es) Composicion de fondaparinux sodico de alta pureza ,un procedimiento de preparacion de esta composicion y composiciones farmaceuticas que la contienen como principio activo
AR019053A1 (es) Uso de 2'2'-difluoronucleosidos para la preparacion de un medicamento y composicion farmaceutica y producto farmaceutico que los contienen
IT1263840B (it) Formulazioni orali di ubidecarenone in forma di capsule
AR005860A1 (es) Compuestos heterociclicos aromaticos, composiciones farmaceuticas y cosmeticas que los contienen, y su utilización.
PE20040324A1 (es) Formulaciones liquidas de baja dosis de entecavir y uso
ES2129448T3 (es) Uso de 2-(2-nitro-4-trifluorometilbenzoil)-1,3-ciclohexanodiona en el tratamiento de tirosinemia y composiciones farmaceuticas.
ES2091183T3 (es) Metodo para mejorar el sueño.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 563094

Country of ref document: ES